Skip to content

Postoperative analgesic effect of tramadol and bupivacaine for cesarean section

Comparison of postoperative analgesic effect of tramadol with bupivacaine for cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201106203468N8
Enrollment
60
Registered
2011-09-22
Start date
1990-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section. Delivery by elective caesarean section

Interventions

Intervention 1: in group 1, surgeon will infiltrate bupivacaine 2 mg/kg subcutaneusely immediately after cesarean. Intervention 2: in group 2, surgeon will infiltrate tramadol 2 mg/kg subcutaneusely
in group 1, surgeon will infiltrate bupivacaine 2 mg/kg subcutaneusely immediately after cesarean.
in group 2, surgeon will infiltrate tramadol 2 mg/kg subcutaneusely immediately after cesarean.

Sponsors

Pain Research Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: complete health condition; first or second time elective cesarean section candidate; age between 18-45 years. Exclusion criteria: sensitivity to study drugs; opium addiction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: 1,2,3 hours after cesarean. Method of measurement: visual analogue scale.;Time to first analgesic request. Timepoint: time between intervention and first analgesic administratin. Method of measurement: minutes.;Total analgesic consumption. Timepoint: 24 after intervention. Method of measurement: mg/kg consumped meperidine.

Secondary

MeasureTime frame
Side effects. Timepoint: 24 hours after intervention. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Atiyeh Gavaheri

Ayatollah Khatami Hospital

atiyeh56@gmail.com+98 35 2572 1401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026